Cargando…
Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response
Protein arginine methyltransferase (PRMT) 5 is over-expressed in a variety of cancers and the master transcription regulator E2F1 is an important methylation target. We have explored the role of PRMT5 and E2F1 in regulating the non-coding genome and report here a striking effect on long non-coding (...
Autores principales: | Barczak, Wojciech, Carr, Simon M., Liu, Geng, Munro, Shonagh, Nicastri, Annalisa, Lee, Lian Ni, Hutchings, Claire, Ternette, Nicola, Klenerman, Paul, Kanapin, Alexander, Samsonova, Anastasia, La Thangue, Nicholas B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968330/ https://www.ncbi.nlm.nih.gov/pubmed/36841868 http://dx.doi.org/10.1038/s41467-023-36826-0 |
Ejemplares similares
-
PRMT5 promotes cancer cell migration and invasion through the E2F pathway
por: Barczak, Wojciech, et al.
Publicado: (2020) -
Arginine methylation expands the regulatory mechanisms and extends the genomic landscape under E2F control
por: Roworth, Alice Poppy, et al.
Publicado: (2019) -
Tudor-domain protein PHF20L1 reads lysine methylated retinoblastoma tumour suppressor protein
por: Carr, Simon M, et al.
Publicado: (2017) -
Linking H1 with chromatin and growth control
por: Munro, Shonagh, et al.
Publicado: (2017) -
The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity
por: Liu, Geng, et al.
Publicado: (2023)